Jørgen Stenderup

Fungemia with Saccharomycetaceae: Report of four Cases and Review of the Literature

Invasive fungal disease with Saccharomycetaceae is very rarely reported and these fungi are usually considered nonpathogenic. We report here 4 cases of positive blood cultures with fungal species belonging to this family. Severe neutropenia, permanent central venous catheter, ongoing antibacterial chemotherapy, and major abdominal surgery were identified as risk factors for fungemia in patients. In the immunocompromised host isolation of such species from sterile fluids cannot be ignored but should be considered an opportunistic infection and treated as such.

Decay of house-dust mite allergen Der f 1 at indoor climatic conditions

BACKGROUND The decay of house-dust mite allergens is important for the outcome of avoidance measures for house-dust mite-allergic patients. OBJECTIVE To quantify the stability of Der f 1 from mattress dust when exposed to domestic conditions. METHODS Three samples of mattress dust were individually homogenized and divided into 64 subsamples. Mites were killed by freezing for 48 hours at -30 degrees C. The subsamples were exposed in eight homes, three storerooms, and one greenhouse, where temperature and relative humidity were recorded. Der f 1 was determined in extracts of subsamples (enzyme-linked immunoadsorbent assay) at 0, 3, 12, and 24 months. RESULTS In the three samples of mattress dust, the initial concentrations of Der f 1 (mean +/- standard deviation; STD) were: 169 (12), 3.9 (0.4), and 31 (2.6) microg/g, respectively. Median half-life of Der f 1 in the mattress dust samples was 10 years in the exposure homes, 18 years in the store rooms, and 1.0 year in the greenhouse. No correlations among preserved Der f 1 and temperature, relative humidity, and absolute humidity in homes were found (Spearman rank correlation test). CONCLUSION Natural decay of Der f 1, with an estimated half-life of 10 years at housing conditions, has no practical consequence in reducing allergen exposure. Therefore, avoidance measures should include an active removal of the allergens.

Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics.

118 episodes of fungemia occurring at Rigshospitalet, Copenhagen, between 1984 and 1988 were reviewed retrospectively. Underlying diseases in the patients were dominated by malignancies, primarily hematological disorders, and intraabdominal diseases requiring major abdominal surgery. Predisposing factors identified in the patients were ongoing antibacterial chemotherapy (83%), central venous catheters (72%), major abdominal surgery (39%), and neutropenia (32%). 120 fungal strains were isolated, of which 88 (73%) were Candida albicans, 23 strains representing 8 other Candida species were also isolated, as were 9 strains belonging to 7 other fungal genera. There were only 5 strains resistant to 5-fluorocytosine (MICs greater than or equal to 25 mg/l), and no strain was resistant to amphotericin B. Treatment with antifungal agents was given in 78 patients, generally a combination of amphotericin B and 5-fluorocytosine. In 14 patients (all non-hematological) the only treatment was removal of a permanent central venous catheter. The outcome was poor in patients with hematological disorders (mortality 76%), whereas patients with malignant and non-malignant intraabdominal diseases had a mortality of 35%. All patients with a permanent central venous catheter as the only risk factor recovered rapidly after removal of the catheter.

Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS or ARC.

From July 1, 1989 to September 5, 1990, 530 serum specimens and 50 cerebrospinal fluid (CSF) specimens from 334 HIV-1 infected patients, most of whom had AIDS or ARC, were analysed in a cryptococcal antigen latex agglutination assay, and all were negative. Three cases of meningitis due to Cryptococcus neoformans diagnosed by microscopy and culture in 3 HIV-1 infected patients are presented. Stored specimens of serum and CSF from these patients were assayed for cryptococcal antigen, and in all 3 the onset of meningitis was preceded by the presence of cryptococcal antigen in serum. It is concluded that the low occurrence of cryptococcosis in our patient population does not justify a routine serum screening for cryptococcal antigen.

Invasive Candida norvegensis Infection in Immunocompromised Patients

Invasive infection with Candida norvegensis has previously been reported only once. Three new cases of invasive infection with C. norvegensis are described. One patient with acute myeloid leukaemia and neutropenic septicaemia had positive blood cultures with C. norvegensis, and 2 patients with AIDS and prolonged unexplained febrile cachexia had positive cultures of C. norvegensis from multiple sites, including pericardium, liver, kidneys lymph nodes and bone marrow, on autopsy. In severely immunocompromised patients, C. norvegensis appears to be an emerging new pathogen.

Cryptococcosis in Denmark: An Analysis of 28 Cases in 1988-1993

A total number of 31 events of systemic cryptococcal infection in 28 patients was identified in a nation-wide survey over 6 years from 1988 to the end of 1993. All medical records were reviewed, 24 of the patients were HIV-infected. Meningitis was diagnosed in 25 patients, and fungemia in 8 patients. The most frequent symptom was headache followed by fever. The median duration in days of fever, headache, and other neurological signs/symptoms before diagnosis was 12, 8 and 2 days, respectively, and, after diagnosis and start of treatments 7, 11 and 12 days, respectively. There was a significant correlation between the duration of headache and the duration of neurological signs/symptoms but not between headache and fever. More than 50% of the patients died within 5 months after the diagnosis. In 39% of the cases, the patients were orally treated with various antifungal drugs before the diagnosis. The rate of cryptococcosis (cumulative) in Danish AIDS patients was estimated to be 1.7%. The HIV-positive patients were, at the time of the cryptococcal diseases, profoundly immunocompromised, with a median CD4+ cell count of 18 (range: 0-78)/microliters. From 24 patients at least 1 isolate of Cryptococcus neoformans was typed, all being var. neoformans, identical with serotype A/D.